|
The specialty pharmaceutical sector continues to experience unprecedented growth, at 6.3 percent in 2010 alone. It is predicted that by 2016, eight of the top 10 branded drugs sold will be specialty pharmaceuticals. Following the publication of three Center specialty-focused research studies in 2011—the Center for Healthcare Supply Chain Research held the first “Specialty Pharmaceutical Supply Chain Issues and Trends Seminar” in Dallas on January 31 and February 1.
Sponsored by AmerisourceBergen Corporation, CuraScript SD Specialty Distribution and Genentech, the seminar provided an opportunity for more than 75 senior-level distributor, manufacturer and other supply chain professionals and stakeholders to examine trends and hot topics in the specialty pharmaceutical segment; discuss the impact of innovations and regulations on the future of this segment; and, network with their peers.
2012 Attendees List
Attendees said: “Specialty Pharmaceutical Supply Chain Issues and Trends Seminar is the 'must attend' conference for the industry. It tackles current issues with the opportunity for industry participants to learn about and brainstorm industry solutions.”
View additional attendee testimonial
To learn more about this seminar or participate in the Center’s specialty pharmaceutical research, contact Kayla Sutton.
| 11:30 AM–12:30 PM |
Seminar Registration |
| 2:00 PM–5:15 PM |
GENERAL SESSIONS
Welcome and Seminar Overview
Karen Ribler, EVP & COO, Center for Healthcare Supply Chain Research
Gayle Johnston, President, CuraScript SD Specialty Distribution, an
Express Scripts Company
|
| 2:15-3:15 PM |
The Present and Future of Specialty Pharmaceuticals
This session will feature a global scope on the trends and issues in the specialty segment of the pharmaceutical supply chain. It will tie in several topics to the global marketplace and provide implications for the U.S.
Speaker: Douglas Long, Vice President, Industry Relations, IMS Health |
| 3:15-4:15 PM |
Reimbursement Issues in Specialty
A perspective on specialty pharmacy and general reimbursement issues in the specialty segment.
Speaker: Kristin Smith, Senior Director, Billing & Reimbursement
Reimbursement Manager, IU Health |
| 4:15-5:15 PM |
Personalized Medicine: Biomarkers and the Advent of New Technologies to Determine Appropriate Care
A discussion on the utilization of biomarkers in specialty care on the pharmaceutical supply chain, including what it means for manufacturers and distributors, distribution channels, product safety, supply chain efficiencies, and more.
Speaker: Gordon Gochenauer from Kantar Health |
| 5:15-6:45 PM |
Exhibits & Reception |
| 6:45 PM |
Open Evening |
|
|
|
|
| |
| 7:30 AM–8:00 AM |
Continental Breakfast |
| 8:00 AM–10:15 AM |
GENERAL SESSIONS
Biosimilars, A Look at Expectations
A perspective on how the introduction of biosimilars will influence the specialty pharmaceutical marketplace.
Speaker: Kara Suter, Director, Xcenda
Roundtable Discussion
Various short presentations will be given on hot topics in the specialty segments, including REMS, different distribution models, and drug shortages. Attendees will have the chance to discuss several topics in small groups.
(Various speakers) |
| 10:15 AM–10:45 AM |
Exhibit Break |
| 10:45 AM–11:30 AM |
Break-Out Sessions
Trends in Specialty Distribution and Manufacturing
Featuring distributor and manufacturer benchmark data and a discussion on trends in the supply chain. Based from the Center’s 2011 publications.
Speaker: Kayla Sutton, Research Manager, Center for Healthcare Supply Chain Research
Information Technology in Oncology
In this session, attendees will learn about information technology from a specialty care management perspective, shedding light on increasing quality and eliminating inefficiencies in cancer care through the use of data.
Speaker: Bill Westfall, Vice President of Sales, New Century Health |
| 11:30 AM–12:30 PM |
GENERAL SESSION
Cold Chain Management
A panel discussion with representation from Sensitech, DDN, UPS Global Healthcare Logistics and CuraScript SD Specialty Distributionon on the rising role of cold chain in the specialty pharmaceutical segment of the industry, including a look at changing regulatory requirements and the impact on the supply chain.
Panel (4) Gayle Johnston, President, CuraScript SD Specialty Distribution, an Express Scripts Company
Mark Maurice, Senior Project Manager, Sensitech
Larry Sweeney, COO, DDN
Kevin Etter, Product Manager, UPS Global Healthcare Logistics Strategy Group
Facilitator:
Karen Ribler, EVP & COO, Center for Healthcare Supply Chain Research |
| 12:30 PM-1:30 PM |
Lunch and Exhibits |
| 1:30-3:30 PM |
GENERAL SESSIONS
Health Information Technology
Using information technology innovation to connect supply chain stakeholders
and provide better patient outcomes.
Speaker: Dan Lodder, Senior Director, Technology and Portals Management, McKesson
Health Outcomes: Leveraging Data to Create a Value Proposition for
Specialty Products
This session will focus on the development of practical health outcomes
information using the wide range of data sets available. Case studies will review
how manufacturers can use this information to launch new products or to
reposition underperforming specialty products due to lack of a strong value
proposition.
Speaker: Thomas Doyle, Vice President, Specialty Solutions, Smith Medical Partners
|
| 3:30 PM |
Seminar Adjournment |
*Agenda subject to change. |